Le Lézard
Classified in: Business
Subject: LAW

DLA Piper advises Edifecs in growth investment from TA Associates and Francisco Partners


NEW YORK, Sept. 24, 2020 /PRNewswire/ -- DLA Piper represented Edifecs, Inc. in a recent growth investment from TA Associates, a leading global growth private equity firm, and Francisco Partners, a leading global technology-focused private equity firm.

Founded in 1996 and headquartered in Bellevue, Washington, Edifecs is a premier technology company in the US healthcare market with solutions focused on interoperability, workflows, value-based care payments and analytics. Since its inception, Edifecs has provided a full range of capabilities to support healthcare entities, including payers, providers, employers, third-party administrators and government agencies. With innovative technology and solutions, the company helps its customers by optimizing the secure exchange and processing of administrative and clinical data, reducing the cost of meeting various regulations and automating workflows involved in multiple core processes within the healthcare ecosystem.

"We were pleased to bring our extensive experience advising healthcare technology companies in complex private equity transactions to support Edifecs in this investment, which will help Edifecs continue to grow and enable it to meet the needs of the rapidly evolving healthcare industry," said Trenton Dykes, the DLA Piper partner who led the firm's deal team.

In addition to Dykes (Seattle), the DLA Piper team representing Edifecs included partners Peter Alfano, Ilya Bubel, James Kelly, Paolo Morante (all of New York) and Cisco Palao-Ricketts (Silicon Valley); senior counsel David Plewa (Silicon Valley); and associates Stasha Loeza, Michael Pirog, Brian Cadousteau, Logan Weaver (all of Seattle) and Patrick Burri (Silicon Valley).

DLA Piper's Private Equity practice includes more than 100 US lawyers who provide strategic counsel to private equity funds and the industry-leading companies they invest in. In 2019, Pitchbook recognized DLA Piper as the second most active private equity law firm globally, further solidifying the strength of the firm's team and its depth of experience executing private equity transactions.

The firm's global Healthcare sector consists of a multidisciplinary legal team with niche experience in health-related business and legal issues. The team regularly works with corporations and financial institutions, private investors, private equity groups, venture capital funds, institutional investors and portfolio companies in all types of healthcare transactions.

About DLA Piper

DLA Piper is a global law firm with lawyers located in more than 40 countries throughout the Americas, Europe, the Middle East, Africa and Asia Pacific, positioning us to help clients with their legal needs around the world. In certain jurisdictions, this information may be considered attorney advertising. dlapiper.com

SOURCE DLA Piper


These press releases may also interest you

at 08:17
On April 25, 2024, the Board of Directors of Woodlands Financial Services Company declared a quarterly cash dividend of twenty-nine cents per share on its common stock, payable on May 24, 2024, to shareholders of record as of May 10, 2024. ...

at 08:14
Trading resumes in: Company: Medicenna Therapeutics Corp. TSX Symbol: MDNA All Issues: Yes Resumption (ET): 8:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts...

at 08:09
Adyton Resources Corporation announces that it has filed its financial statements for the three and twelve months ended December 31, 2023 and accompanying Management Discussion and Analysis on its SEDAR profile at www.sedar.com. ...

at 08:07
The following issues have been halted by CIRO: Company: Medicenna Therapeutics Corp. TSX Symbol: MDNA All Issues: Yes Reason: Pending News Halt Time (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a...

at 08:05
Cutera, Inc. ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024....

at 08:05
The Beauty Health Company , home to flagship brand Hydrafacialtm, today announced it will report first quarter 2024 financial results after market close on Thursday, May 9, 2024. The Company will host an investor conference call at 4:30 p.m. Eastern...



News published on and distributed by: